Using this list to filter our transcriptomic datasets of PMBL versus DLBCL patient samples, we identified 9 FOXP1 targets: 3 downregulated by FOXP1 (DERL3, TTC28, and TPRA1), and 6 upregulated by FOXP1 (FMNL3, DNAJB6, KMO, SNX29, ERP44, and CD80). Here, CD80 is linked to diffuse large B-cell lymphoma.